ロード中...
Should Higher Vancomycin Trough Levels Be Targeted for Invasive Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in Children?
Methicillin-resistant Staphylococcus aureus (MRSA) isolates with vancomycin minimal inhibitory concentrations (MIC's) ≥ 1.5 μg/mL have been associated with poorer clinical outcomes and treatment failures in adults. We evaluated vancomycin MIC's in 71 invasive pediatric community-acquired M...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3848324/ https://ncbi.nlm.nih.gov/pubmed/19935448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0b013e3181c52a04 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|